Effective post-exposure treatment of Ebola infection.
Ebola viruses are highly lethal human pathogens that have received considerable attention in recent years due to an increasing re-emergence in Central Africa and a potential for use as a biological weapon. There is no vaccine or treatment licensed for human use. In the past, however, important advan...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2007-01-01
|
Series: | PLoS Pathogens |
Online Access: | https://doi.org/10.1371/journal.ppat.0030002 |
id |
doaj-dc87aac089584cbe91e9faa77525e565 |
---|---|
record_format |
Article |
spelling |
doaj-dc87aac089584cbe91e9faa77525e5652021-04-21T17:09:33ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742007-01-0131e210.1371/journal.ppat.0030002Effective post-exposure treatment of Ebola infection.Heinz FeldmannSteven M JonesKathleen M Daddario-DiCaprioJoan B GeisbertUte StröherAllen GrollaMike BrayElizabeth A FritzLisa FernandoFriederike FeldmannLisa E HensleyThomas W GeisbertEbola viruses are highly lethal human pathogens that have received considerable attention in recent years due to an increasing re-emergence in Central Africa and a potential for use as a biological weapon. There is no vaccine or treatment licensed for human use. In the past, however, important advances have been made in developing preventive vaccines that are protective in animal models. In this regard, we showed that a single injection of a live-attenuated recombinant vesicular stomatitis virus vector expressing the Ebola virus glycoprotein completely protected rodents and nonhuman primates from lethal Ebola challenge. In contrast, progress in developing therapeutic interventions against Ebola virus infections has been much slower and there is clearly an urgent need to develop effective post-exposure strategies to respond to future outbreaks and acts of bioterrorism, as well as to treat laboratory exposures. Here we tested the efficacy of the vesicular stomatitis virus-based Ebola vaccine vector in post-exposure treatment in three relevant animal models. In the guinea pig and mouse models it was possible to protect 50% and 100% of the animals, respectively, following treatment as late as 24 h after lethal challenge. More important, four out of eight rhesus macaques were protected if treated 20 to 30 min following an otherwise uniformly lethal infection. Currently, this approach provides the most effective post-exposure treatment strategy for Ebola infections and is particularly suited for use in accidentally exposed individuals and in the control of secondary transmission during naturally occurring outbreaks or deliberate release.https://doi.org/10.1371/journal.ppat.0030002 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Heinz Feldmann Steven M Jones Kathleen M Daddario-DiCaprio Joan B Geisbert Ute Ströher Allen Grolla Mike Bray Elizabeth A Fritz Lisa Fernando Friederike Feldmann Lisa E Hensley Thomas W Geisbert |
spellingShingle |
Heinz Feldmann Steven M Jones Kathleen M Daddario-DiCaprio Joan B Geisbert Ute Ströher Allen Grolla Mike Bray Elizabeth A Fritz Lisa Fernando Friederike Feldmann Lisa E Hensley Thomas W Geisbert Effective post-exposure treatment of Ebola infection. PLoS Pathogens |
author_facet |
Heinz Feldmann Steven M Jones Kathleen M Daddario-DiCaprio Joan B Geisbert Ute Ströher Allen Grolla Mike Bray Elizabeth A Fritz Lisa Fernando Friederike Feldmann Lisa E Hensley Thomas W Geisbert |
author_sort |
Heinz Feldmann |
title |
Effective post-exposure treatment of Ebola infection. |
title_short |
Effective post-exposure treatment of Ebola infection. |
title_full |
Effective post-exposure treatment of Ebola infection. |
title_fullStr |
Effective post-exposure treatment of Ebola infection. |
title_full_unstemmed |
Effective post-exposure treatment of Ebola infection. |
title_sort |
effective post-exposure treatment of ebola infection. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS Pathogens |
issn |
1553-7366 1553-7374 |
publishDate |
2007-01-01 |
description |
Ebola viruses are highly lethal human pathogens that have received considerable attention in recent years due to an increasing re-emergence in Central Africa and a potential for use as a biological weapon. There is no vaccine or treatment licensed for human use. In the past, however, important advances have been made in developing preventive vaccines that are protective in animal models. In this regard, we showed that a single injection of a live-attenuated recombinant vesicular stomatitis virus vector expressing the Ebola virus glycoprotein completely protected rodents and nonhuman primates from lethal Ebola challenge. In contrast, progress in developing therapeutic interventions against Ebola virus infections has been much slower and there is clearly an urgent need to develop effective post-exposure strategies to respond to future outbreaks and acts of bioterrorism, as well as to treat laboratory exposures. Here we tested the efficacy of the vesicular stomatitis virus-based Ebola vaccine vector in post-exposure treatment in three relevant animal models. In the guinea pig and mouse models it was possible to protect 50% and 100% of the animals, respectively, following treatment as late as 24 h after lethal challenge. More important, four out of eight rhesus macaques were protected if treated 20 to 30 min following an otherwise uniformly lethal infection. Currently, this approach provides the most effective post-exposure treatment strategy for Ebola infections and is particularly suited for use in accidentally exposed individuals and in the control of secondary transmission during naturally occurring outbreaks or deliberate release. |
url |
https://doi.org/10.1371/journal.ppat.0030002 |
work_keys_str_mv |
AT heinzfeldmann effectivepostexposuretreatmentofebolainfection AT stevenmjones effectivepostexposuretreatmentofebolainfection AT kathleenmdaddariodicaprio effectivepostexposuretreatmentofebolainfection AT joanbgeisbert effectivepostexposuretreatmentofebolainfection AT utestroher effectivepostexposuretreatmentofebolainfection AT allengrolla effectivepostexposuretreatmentofebolainfection AT mikebray effectivepostexposuretreatmentofebolainfection AT elizabethafritz effectivepostexposuretreatmentofebolainfection AT lisafernando effectivepostexposuretreatmentofebolainfection AT friederikefeldmann effectivepostexposuretreatmentofebolainfection AT lisaehensley effectivepostexposuretreatmentofebolainfection AT thomaswgeisbert effectivepostexposuretreatmentofebolainfection |
_version_ |
1714666546030182400 |